Dr. Reddy's Loses Zyprexa Patent Fight In UK Court

Law360, New York (December 18, 2009, 4:48 PM EST) -- A U.K. appeals court has upheld the validity of Eli Lilly & Co.'s patent for Zyprexa, rejecting Dr. Reddy's Laboratories Ltd.'s contention that an earlier Lilly patent rendered the patent for the blockbuster schizophrenia drug invalid.

The High Court of Justice, Court of Appeal, sided with Lilly on Friday, shooting down the Dr. Reddy's challenge and affirming a decision by the High Court of Justice, Chancery Division.

The generic-drug maker had argued that a disclosure for a prior Lilly patent for a broad class of compounds...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.